GL1X · GenesisL1 explorer

MolNFT v1 · #185675 · protein

JAK2 in complex with 4-(2-amino-8-{[(2S)-1-hydroxypropan-2- YL]AMINO}QUINAZOLIN-6-yl)-5-ethyl-2-fluorophenol

7Q7L · Tyrosine-protein kinase JAK2: “JAK2 in complex with 4-(2-amino-8-{[(2S)-1-hydroxypropan-2- YL]AMINO}QUINAZOLIN-6-yl)-5-ethyl-2-fluorophenol”. X-ray diffraction, 1 ligand (9I2), 3 pockets (best druggability 0.68). MolNFT v1 #185675…

PDB
7Q7L
Type
protein
Length
289 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
9I2
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28945% helix, 20% strandO60674

Ligands and binding sites

  • 9I2 · 4-[2-azanyl-8-[[(2~{S})-1-oxidanylpropan-2-yl]amino]quinazolin-6-yl]-5-ethyl-2-fluoranyl-phenol · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12060.680.85269I2, GOL
21600.500.7830empty
3860.330.7322empty

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 7Q7L · JAK2 in complex with 4-(2-amino-8-{[(2S)-1-hydroxypropan-2-yl]amino}quinazolin-6-yl)-5-eth… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.